Daré Bioscience
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $1,023 | $2 | $-21 | $25 |
Gross Profit | 58 | -610 | -21 | -2,271 |
EBITDA | -802 | -2,736 | -3,367 | -4,423 |
EBIT | -1,471 | -3,349 | -3,827 | -4,581 |
Net Income | -1,441 | -3,562 | -4,016 | -4,378 |
Net Change In Cash | 1,023 | 2 | -21 | 25 |
Free Cash Flow | 1,237 | -616 | -5,264 | -5,627 |
Cash | 24,711,356 | 23,075 | 5,035 | 10,329 |
Basic Shares | 14,499 | 12,755 | 8,871 | 8,759 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $1,030 | $9 | $2,807 | $10,000 |
Gross Profit | -1,416 | -14,295 | -18,830 | 10,000 |
EBITDA | -11,400 | -23,409 | -30,701 | -31,361 |
EBIT | -13,552 | -23,451 | -30,739 | -31,385 |
Net Income | -13,399 | -4,053 | -30,161 | 406,802 |
Net Change In Cash | 1,030 | 9 | 2,807 | 10,000 |
Free Cash Flow | -10,271,148 | 4,821 | -39,486 | -18,151 |
Cash | 24,711,356 | 15,698 | 10,476 | 34,669 |
Basic Shares | 111,787 | 8,497 | 7,275 | 7,048 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | -$0.10 |
2025-09-30 | -$0.28 |
2025-06-30 | -$0.45 |
2025-03-31 | -$0.50 |